Peptide Synthesis and Purification Core Facility
Peptide Synthesis and Purification Core Facility
批准号:
7466200
负责人:
G M ANANTHARAMAIAH
金额:
$11.95万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-05-01 至 2013-03-31
关键词:
Alzheimer&aposs DiseaseAmino AcidsApolipoproteins AAtherosclerosisBiologyBlood VesselsCore FacilityCost SavingsCountryCultured CellsDiabetes MellitusDiseaseDrug or chemical Tissue DistributionFatty AcidsGlassGoalsHigh Density LipoproteinsHigh Pressure Liquid ChromatographyHome environmentInflammatoryLabelLaboratoriesLengthLiquid ChromatographyLiteratureMethodsNumbersOperative Surgical ProceduresPaperPeptide SynthesisPeptidesPhasePhiladelphiaPlant ResinsProceduresProcessProteinsPublicationsPublishingRadiolabeledReactionRecombinant ProteinsResearchResearch DesignResearch PersonnelRoleSiteStagingStructureSystemTechnologyTimeUnited States National Institutes of HealthUniversitiesWashingtonWisconsinbasedayfast protein liquid chromatographyimprovedin vivoinstrumentationmimeticspeptide analogpressureprogramsradiotracersilochromesizesynthetic peptide
中文摘要
A.局该设施将为主要描述的研究提供合成肽
项目2、3和4。该核心由Anantharamaiah博士指导,Palgunachari博士将协助
这个设施的日常运作这一核心设施的生产力很高,
广泛支持该计划项目,因此,该计划的重要组成部分
项目应用。
B。仪器仪表。该设施拥有三个蛋白质技术自动肽
合成器和一个Advanced ChemTech(ACT 90)肽合成器。而蛋白质
技术肽合成器可以提供少量的肽(mg量),
更短的持续时间,因为在氨基上添加了十倍过量的进入氨基酸,
酸性树脂,ACT可以提供10 g量的肽,但由于一个氨基酸,
在合成的每个阶段确定反应完成后,每天加入酸。
由于ACT 90中使用的起始树脂更多,我们避免添加超过所需过量的
在每一阶段都使用氨基酸衍生物,以节省氨基酸衍生物的成本。为
核心设施拥有三台Beckman分析型HPLC和两台
制备型HPLC单元(Beckman和Varian)。除此之外,核心设施还利用BioRad
连接至Michel Muller中压液相色谱仪的FPLC系统
(MPLC)玻璃柱。这些列的大小不同,最小的(分析)列包含
12 g固定相(C-4或C-18硅胶)和含有800 g
“自制”反相固定相(C-4和C-18反相硅胶)。我们
通常用各种链长的脂肪酸烷基化硅胶。我们一次生产2公斤,
国产色谱柱固定相为4kg。这提供了更高的能力,以净化大
大量的合成肽。这些柱也用于纯化重组蛋白。一
典型的程序将在方法部分中描述。
英文摘要
A. Administration. This facility will provide synthetic peptides for studies described mainly in
projects 2, 3 and 4. This core is directed by Dr. Anantharamaiah, and Dr. Palgunachari will assist in
the day-to-day operation of this facility. This core facility has been highly productive and has
supported this program project extensively and therefore, an important component of this program
project application.
B. Instrumentation. The facility possesses three Protein Technology automatic peptide
synthesizers and one Advanced ChemTech (ACT 90) peptide synthesizer. While the Protein
Technology peptide synthesizers can provide small amounts of the peptides (in mg quantities) in a
shorter duration due to the addition of ten times excess of incoming amino acids on to the amino
acid-resin, the ACT can provide 10g quantities of peptides but the process is slow since one amino
acid is added per day after the completion of reaction is ascertained at each stage of the synthesis.
Since the starting resin used in ACT 90 is more, we avoid adding more than the required excess of
amino acid derivatives at each stage in order to save costs on amino acid derivatives. For the
purification of peptides the core facility possesses three Beckman analytical HPLC and two
preparative HPLC units (Beckman and Varian). In addition to this, the core facility utilizes BioRad
FPLC systems that are connected to Michel Muller Medium Pressure Liquid Chromatography
(MPLC) glass columns. These columns are of various sizes with the smallest (analytical) containing
12g of the stationary phase (C-4 or C-18 silica gel) and the biggest column containing 800g of
"home made" reverse phase stationary phase (C-4 and C-18 Reversed Phase silica gels). We
routinely alkylate Silica Gel with various chain-lengths of fatty acids. At a time we produce 2 kg to
4kg of the stationary phase for home made columns. This provides a higher capacity to purify large
quantities of synthetic peptides. These columns are also used to purify recombinant proteins. A
typical procedure will be described in the Methods Section.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HDL and Cellular Repair Mechanisms
-
批准号:9215669
-
项目类别:
-
资助金额:$33.08万
-
财政年份:2016
-
负责人:G M ANANTHARAMAIAH
-
依托单位:
Cellular Lipids and Leukocyte Function
-
批准号:9313269
-
项目类别:
-
资助金额:$29.03万
-
财政年份:2015
-
负责人:G M ANANTHARAMAIAH
-
依托单位:
Modulators of HDL Structure-Function
-
批准号:8242747
-
项目类别:
-
资助金额:$23.96万
-
财政年份:2011
-
负责人:G M ANANTHARAMAIAH
-
依托单位:
Peptide Synthesis and Purification Core Facility
-
批准号:8242749
-
项目类别:
-
资助金额:$23.96万
-
财政年份:2011
-
负责人:G M ANANTHARAMAIAH
-
依托单位:
Apo E mimetics reduce cholesterol and improve HDL function
-
批准号:7867924
-
项目类别:
-
资助金额:$41.71万
-
财政年份:2008
-
负责人:G M ANANTHARAMAIAH
-
依托单位:
Apo E mimetics reduce cholesterol and improve HDL function
-
批准号:7666804
-
项目类别:
-
资助金额:$41.33万
-
财政年份:2008
-
负责人:G M ANANTHARAMAIAH
-
依托单位:
Apo E mimetics reduce cholesterol and improve HDL function
-
批准号:8111688
-
项目类别:
-
资助金额:$41.3万
-
财政年份:2008
-
负责人:G M ANANTHARAMAIAH
-
依托单位:
Modulators of HDL Structure-Function
-
批准号:7466153
-
项目类别:
-
资助金额:$43.36万
-
财政年份:2008
-
负责人:G M ANANTHARAMAIAH
-
依托单位:
Modulators of HDL structure-function
-
批准号:7298870
-
项目类别:
-
资助金额:$36.25万
-
财政年份:2007
-
负责人:G M ANANTHARAMAIAH
-
依托单位:
Enhanced Hepatic Lipoprotein Uptake and Atherogenesis
-
批准号:6527643
-
项目类别:
-
资助金额:$35.88万
-
财政年份:2001
-
负责人:G M ANANTHARAMAIAH
-
依托单位:
Enhanced Hepatic Lipoprotein Uptake and Atherogenesis
-
批准号:6656302
-
项目类别:
-
资助金额:$35.88万
-
财政年份:2001
-
负责人:G M ANANTHARAMAIAH
-
依托单位:
Enhanced Hepatic Lipoprotein Uptake and Atherogenesis
-
批准号:6371033
-
项目类别:
-
资助金额:$35.88万
-
财政年份:2001
-
负责人:G M ANANTHARAMAIAH
-
依托单位:
Enhanced Hepatic Lipoprotein Uptake and Atherogenesis
-
批准号:6793248
-
项目类别:
-
资助金额:$35.88万
-
财政年份:2001
-
负责人:G M ANANTHARAMAIAH
-
依托单位:
DETERMINANTS OF ATHEROSCLEROSIS PROTECTION
-
批准号:6327704
-
项目类别:
-
资助金额:$17.62万
-
财政年份:2000
-
负责人:G M ANANTHARAMAIAH
-
依托单位:
CORE--PEPTIDE SYTHESIS
-
批准号:6327706
-
项目类别:
-
资助金额:$17.62万
-
财政年份:2000
-
负责人:G M ANANTHARAMAIAH
-
依托单位:
DETERMINANTS OF ATHEROSCLEROSIS PROTECTION
-
批准号:6109782
-
项目类别:
-
资助金额:$17.62万
-
财政年份:1999
-
负责人:G M ANANTHARAMAIAH
-
依托单位:
CORE--PEPTIDE SYTHESIS
-
批准号:6109784
-
项目类别:
-
资助金额:$17.62万
-
财政年份:1999
-
负责人:G M ANANTHARAMAIAH
-
依托单位:
CORE--PEPTIDE SYTHESIS
-
批准号:6272741
-
项目类别:
-
资助金额:$17.69万
-
财政年份:1998
-
负责人:G M ANANTHARAMAIAH
-
依托单位:
DETERMINANTS OF ATHEROSCLEROSIS PROTECTION
-
批准号:6272739
-
项目类别:
-
资助金额:$17.69万
-
财政年份:1998
-
负责人:G M ANANTHARAMAIAH
-
依托单位:
DETERMINANTS OF ATHEROSCLEROSIS PROTECTION
-
批准号:6241882
-
项目类别:
-
资助金额:$18.5万
-
财政年份:1997
-
负责人:G M ANANTHARAMAIAH
-
依托单位:
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
-
批准号:81000622
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:梁胜
-
依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
-
批准号:31060293
-
项目类别:地区科学基金项目
-
资助金额:26.0万元
-
批准年份:2010
-
负责人:郭亚芬
-
依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
-
批准号:30960334
-
项目类别:地区科学基金项目
-
资助金额:22.0万元
-
批准年份:2009
-
负责人:董贵成
-
依托单位: